A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2018
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 22 Jun 2018 Planned End Date changed from 1 Jun 2018 to 1 Jul 2018.
- 22 Jun 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.
- 28 Nov 2017 Status changed from not yet recruiting to recruiting.